journal article·2025-10-08Open access

Chronic Kidney Disease and Oral Health: A Cross-Sectional Study

Michele Basilicata, Manuela Di Lauro, Giovanni Bruno, Kevin Cornali, Giulia Marrone, Claudia Masci, Giuseppe Troiano, Simone Manca di Villahermosa, Anna Paola Mitterhofer, Patrizio Bollero, Annalisa Noce

Applied Sciences· Volume 15· Issue 19

Abstract

Objective: This pilot study investigated the association between chronic kidney disease (CKD) and oral health, focusing on the prevalence and severity of periodontal disease (PD) in the different CKD stages. Moreover, we explored how systemic alterations related to kidney dysfunction may influence oral conditions. Methods: A cross-sectional observational study was conducted on seventy-five adult CKD patients (stages G1–G5) under conservative therapy. Participants underwent clinical, biochemical, and dental assessments. Periodontal parameters, such as the plaque index, bleeding on probing, clinical attachment loss, and gingival recession, were evaluated. Results: A significant inverse relationship was found between the estimated glomerular filtration rate (e-GFR) and PD severity, plaque index, and gingival inflammation. Advanced CKD patients exhibited a higher prevalence of generalized gingivitis and more severe PD stages and grades. Patients with e-GFR below 44 mL/min/1.73 m2 had a 3.3-fold higher risk of developing PD. In our population, the prevalence of xerostomia and dysgeusia was 45% and 15%, respectively, with taste alteration correlating directly with declining kidney function. Conclusions: CKD patients demonstrate compromised oral health, with an increased risk of PD. Renal dysfunction appears to be a significant factor influencing the onset and progression of PD. Further studies are necessary to clarify the underlying mechanisms and to develop integrated management strategies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Oral Health Pathology and Treatment · Dental Health and Care Utilization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

UOSD Special Care Dentistry, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, 00133 Rome, Italy

Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy

Department of Neuroscience, School of Dentistry, University of Padova, 35121 Padova, Italy

Department of Industrial Engineering, University of Rome Tor Vergata, 00133 Rome, Italy

Department of Experimental Medicine, PhD School in Biochemistry and Molecular Biology, University of Rome Tor Vergata, 00133 Rome, Italy

Department of Medicine and Surgery, University LUM, 70010 Bari, Italy

UOSD Nephrology and Dialysis, Policlinico Tor Vergata, 00133 Rome, Italy

UOSD Special Care Dentistry, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy

References (44)

Show source-provided references
1. GBD Chronic Kidney Disease Collaboration (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 395, 709–733.
2. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories10.1016/S0140-6736(18)31694-5 ↗
3. Noce, A., Marrone, G., Wilson Jones, G., Di Lauro, M., Pietroboni Zaitseva, A., Ramadori, L., Celotto, R., Mitterhofer, A.P., and Di Daniele, N. (2021). Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease. Nutrients, 13.10.3390/nu13082534 ↗
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117–S314.10.1016/j.kint.2023.10.018 ↗
5. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: Evolution not revolution10.1373/clinchem.2012.184259 ↗
6. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease10.1038/nrneph.2017.181 ↗
7. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age10.1038/sj.ki.5000058 ↗
8. The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden10.1053/j.ajkd.2005.07.040 ↗
9. Lifetime incidence of CKD stages 3–5 in the United States10.1053/j.ajkd.2013.03.009 ↗
10. Epidemiology of chronic kidney disease: An update 202210.1016/j.kisu.2021.11.003 ↗
11. Chronic kidney disease10.1016/S0140-6736(21)00519-5 ↗
12. Canale, M.P., Noce, A., Di Lauro, M., Marrone, G., Cantelmo, M., Cardillo, C., Federici, M., Di Daniele, N., and Tesauro, M. (2021). Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review. Nutrients, 13.10.3390/nu13041162 ↗
13. Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study
14. Basilicata, M., Di Lauro, M., Campolattano, V., Marrone, G., Celotto, R., Mitterhofer, A.P., Bollero, P., Di Daniele, N., and Noce, A. (2022). Natural Bioactive Compounds in the Management of Oral Diseases in Nephropathic Patients. Int. J. Environ. Res. Public Health, 19.10.3390/ijerph19031665 ↗
15. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease10.1038/ki.2008.516 ↗
16. Halitosis, reduced salivary flow and the quality of life in pre-kidney transplantation patients10.4317/jced.57282 ↗
17. Bidirectional Interaction Between Chronic Kidney Disease and Porphyromonas gingivalis Infection Drives Inflammation and Immune Dysfunction10.1155/jimr/8355738 ↗
18. Pathophysiology, therapy, and oral implications of renal failure in children and adolescents: An update
19. The etiology of enamel hypoplasia: A unifying concept10.1016/S0022-3476(81)80580-X ↗
20. Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems10.1002/jps.2600760506 ↗
21. Costacurta, M., Di Lauro, M., Cornali, K., Docimo, R., and Noce, A. (2025). Developmental Defects of Enamel and Dental Caries in Pediatric Patients with Chronic Kidney Disease–Mineral Bone Disorders. Appl. Sci., 15.10.3390/app15031164 ↗
22. Association between periodontitis and chronic kidney disease10.1111/prd.12431 ↗
23. Gasner, N.S., and Schure, R.S. (2025). Periodontal Disease, StatPearls.
24. Kozak, M., and Pawlik, A. (2023). The Role of the Oral Microbiome in the Development of Diseases. Int. J. Mol. Sci., 24.10.3390/ijms24065231 ↗
25. Bhuyan, R., Bhuyan, S.K., Mohanty, J.N., Das, S., Juliana, N., and Juliana, I.F. (2022). Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms. Biomedicines, 10.10.3390/biomedicines10102659 ↗
26. Periodontal disease and other nontraditional risk factors for CKD10.1053/j.ajkd.2007.09.018 ↗
27. Fusobacterium nucleatum-infected periodontitis promotes renal interstitial fibrosis in rats through the TGF-beta/SMAD2/3 and beta-catenin signaling pathways10.1016/j.gene.2024.148729 ↗
28. Li, L., Zhang, Y.L., Liu, X.Y., Meng, X., Zhao, R.Q., Ou, L.L., Li, B.Z., and Xing, T. (2021). Periodontitis Exacerbates and Promotes the Progression of Chronic Kidney Disease Through Oral Flora, Cytokines, and Oxidative Stress. Front. Microbiol., 12.10.3389/fmicb.2021.656372 ↗
29. Periodontitis regulates renal impairment in obese mice via TGF-beta/Smad pathway
30. American Academy of Periodontology (2011). Comprehensive periodontal therapy: A statement by the American Academy of Periodontology. J. Periodontol., 82, 943–949.10.1902/jop.2011.117001 ↗
31. A new classification scheme for periodontal and peri-implant diseases and conditions—Introduction and key changes from the 1999 classification10.1111/jcpe.12935 ↗
32. Systemic consequences of poor oral health in chronic kidney disease patients10.2215/CJN.05470610 ↗
33. Oral health challenges in patients with chronic kidney disease: A comprehensive clinical assessment10.1016/j.sdentj.2023.11.026 ↗
34. Oral health-related quality of life in chronic kidney disease patients10.4103/1735-3327.351344 ↗
35. Basilicata, M., Pieri, M., Marrone, G., Nicolai, E., Di Lauro, M., Paolino, V., Tomassetti, F., Vivarini, I., Bollero, P., and Bernardini, S. (2023). Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases. Metabolites, 13.10.3390/metabo13080889 ↗
36. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients10.1016/j.jtemb.2009.06.005 ↗
37. Basha, M.M., Al-Kadasi, B.A., Al-Hajri, M., Al-Sharani, H.M., and Elayah, S.A. (2024). Exploring the correlation between periodontal disease and serum biomarkers in haemodialysis patients. BMC Oral. Health, 24.10.1186/s12903-024-04826-1 ↗
38. Dembowska, E., Jaron, A., Raslawska-Socha, J., Gabrysz-Trybek, E., Bladowska, J., Gacek, S., and Trybek, G. (2022). The Evaluation of the Periodontal Status of Hemodialysis Patients with End-Stage Renal Disease. J. Clin. Med., 11.10.3390/jcm11040975 ↗
39. Meta-analysis of the association between chronic periodontitis and chronic kidney disease10.12998/wjcc.v12.i22.5094 ↗
40. Belluz, M., and Longhi, E. (2023). Periodontal Disease. Managing Psychosexual Consequences in Chronic Diseases, Springer International Publishing.10.1007/978-3-031-31307-3_27 ↗
41. Xerostomia in the Geriatric Patient: Causes, Oral Manifestations, and Treatment
42. Oral implications of polypharmacy in the elderly10.1016/j.cden.2014.07.004 ↗
43. Erythrocyte glutathione transferase activity: A possible early biomarker for blood toxicity in uremic diabetic patients10.1007/s00592-013-0497-3 ↗
44. Structure and Function of the 26S Proteasome10.1146/annurev-biochem-062917-011931 ↗